Kalscheuer Vera M, James Victoria M, Himelright Miranda L, Long Philip, Oegema Renske, Jensen Corinna, Bienek Melanie, Hu Hao, Haas Stefan A, Topf Maya, Hoogeboom A Jeannette M, Harvey Kirsten, Walikonis Randall, Harvey Robert J
Department of Human Molecular Genetics, Max Planck Institute for Molecular GeneticsBerlin, Germany; Research Group Development and Disease, Max Planck Institute for Molecular GeneticsBerlin, Germany.
Department of Pharmacology, UCL School of Pharmacy London, UK.
Front Mol Neurosci. 2016 Jan 11;8:85. doi: 10.3389/fnmol.2015.00085. eCollection 2015.
Disease gene discovery in neurodevelopmental disorders, including X-linked intellectual disability (XLID) has recently been accelerated by next-generation DNA sequencing approaches. To date, more than 100 human X chromosome genes involved in neuronal signaling pathways and networks implicated in cognitive function have been identified. Despite these advances, the mutations underlying disease in a large number of XLID families remained unresolved. We report the resolution of MRX78, a large family with six affected males and seven affected females, showing X-linked inheritance. Although a previous linkage study had mapped the locus to the short arm of chromosome X (Xp11.4-p11.23), this region contained too many candidate genes to be analyzed using conventional approaches. However, our X-chromosome exome resequencing, bioinformatics analysis and inheritance testing revealed a missense mutation (c.C2366T, p.A789V) in IQSEC2, encoding a neuronal GDP-GTP exchange factor for Arf family GTPases (ArfGEF) previously implicated in XLID. Molecular modeling of IQSEC2 revealed that the A789V substitution results in the insertion of a larger side-chain into a hydrophobic pocket in the catalytic Sec7 domain of IQSEC2. The A789V change is predicted to result in numerous clashes with adjacent amino acids and disruption of local folding of the Sec7 domain. Consistent with this finding, functional assays revealed that recombinant IQSEC2(A789V) was not able to catalyze GDP-GTP exchange on Arf6 as efficiently as wild-type IQSEC2. Taken together, these results strongly suggest that the A789V mutation in IQSEC2 is the underlying cause of XLID in the MRX78 family.
包括X连锁智力障碍(XLID)在内的神经发育障碍疾病基因的发现,最近因新一代DNA测序方法而加速。迄今为止,已鉴定出100多个参与神经元信号通路和认知功能相关网络的人类X染色体基因。尽管有这些进展,但大量XLID家族疾病的潜在突变仍未得到解决。我们报告了MRX78家系疾病基因的解析,该家系有6名患病男性和7名患病女性,呈X连锁遗传。尽管先前的连锁研究已将该基因座定位到X染色体短臂(Xp11.4 - p11.23),但该区域包含太多候选基因,无法用传统方法进行分析。然而,我们的X染色体外显子重测序、生物信息学分析和遗传测试揭示了IQSEC2基因中的一个错义突变(c.C2366T,p.A789V),该基因编码一种Arf家族GTP酶(ArfGEF)的神经元GDP - GTP交换因子,此前已被认为与XLID有关。IQSEC2的分子建模显示,A789V替代导致一个更大的侧链插入IQSEC2催化性Sec7结构域的疏水口袋中。预计A789V变化会导致与相邻氨基酸发生大量冲突,并破坏Sec7结构域的局部折叠。与此发现一致,功能测定表明,重组IQSEC2(A789V)不能像野生型IQSEC2那样有效地催化Arf6上的GDP - GTP交换。综上所述,这些结果强烈表明,IQSEC2基因中的A789V突变是MRX78家系XLID的根本原因。